Suppr超能文献

射频消融治疗后甲状腺结节的超声表现差异。

Differences in the ultrasonographic appearance of thyroid nodules after radiofrequency ablation.

机构信息

Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.

Graduate Institute of Industrial Engineering, National Taiwan University, Taipei, Taiwan.

出版信息

Clin Endocrinol (Oxf). 2021 Sep;95(3):489-497. doi: 10.1111/cen.14480. Epub 2021 May 3.

Abstract

CONTEXT

Radiofrequency ablation (RFA) is a well-tolerated approach to treating benign thyroid nodules (TNs), but no index can predict its success. Other than size decrease, little is known about TN appearance on ultrasonography (US) after RFA.

OBJECTIVE

This study aimed to (a) assess the effectiveness of single-session RFA treatment, (b) determine whether pre-ablation US characteristics correlate with its effectiveness, and (c) demonstrate TN characteristics on baseline and follow-up US.

DESIGN

Retrospective cohort study among the patients who underwent single-session RFA for the treatment of benign TNs at a referral medical center between January 2018 and April 2019.

PATIENTS

A total of 116 patients (137 nodules) were included in the study.

MEASUREMENTS

Characteristics were quantified using commercial software. TNs were classified into 2015 American Thyroid Association (ATA) sonographic patterns and American College of Radiology Thyroid Imaging Reporting and Data System (ACR-TI-RADS) categories.

RESULTS

The average volume reduction ratio (VRR) was 74.51% in 1 year (95% confidence interval, 70.63%-78.39%). The only pre-ablation US feature significantly different between nodules with VRR <50% and VRR >50% was the cyst composition (0.05 vs. 0.02, p-value = .02). The VRR and margin change in the first 3 months after ablation were found to be leading indicators significantly correlated to the VRR in 6 months with correlation coefficients (r) = .72 and -.28 (p-value < .0001 and = .0008) and VRR in 1 year with r = .65 and -.17 (p-value < .0001 and = .046), respectively. After RFA, more TNs became ATA high suspicion (2.9% vs. 19.7%, p < .0001) and more appeared to be the non-ATA patterns (12.4% vs. 23.4%, p < .0001). Also, a greater number of post-RFA TNs were classified as ACR-TI-RADS categories 4 and 5 (40.1% vs. 70.1%, p < .0001).

CONCLUSIONS

Radiofrequency ablation therapy is effective for treating TNs. Pre-ablation cyst components, 3-month post-ablation volume reduction and margin change of TNs were related to the 6-month and 1-year response. Clinicians should consider that TNs would appear peculiar on US after RFA, mistakenly suggesting malignant potential.

摘要

背景

射频消融(RFA)是治疗良性甲状腺结节(TN)的一种耐受良好的方法,但没有指标可以预测其疗效。除了体积减小外,人们对 RFA 后 TN 在超声检查(US)中的外观知之甚少。

目的

本研究旨在:(a)评估单次 RFA 治疗的效果,(b)确定消融前 US 特征是否与疗效相关,以及(c)显示 TN 在基线和随访 US 中的特征。

设计

对 2018 年 1 月至 2019 年 4 月在转诊医疗中心接受单次 RFA 治疗的良性 TN 患者进行回顾性队列研究。

患者

共有 116 名患者(137 个结节)纳入研究。

测量

使用商业软件对特征进行量化。TN 分为 2015 年美国甲状腺协会(ATA)超声模式和美国放射学院甲状腺成像报告和数据系统(ACR-TI-RADS)类别。

结果

1 年内平均体积减少率(VRR)为 74.51%(95%置信区间,70.63%-78.39%)。VRR <50%和 VRR >50%的结节之间唯一的消融前 US 特征是囊肿成分不同(0.05 对 0.02,p 值=0.02)。消融后 3 个月的 VRR 和边缘变化被发现是与 6 个月和 1 年 VRR 显著相关的主要指标,相关系数(r)分别为 0.72 和 -0.28(p 值均<0.0001 和=0.0008)和 0.65 和 -0.17(p 值均<0.0001 和=0.046)。RFA 后,更多的 TN 被归类为 ATA 高度可疑(2.9%对 19.7%,p<0.0001),更多的 TN 出现非 ATA 模式(12.4%对 23.4%,p<0.0001)。此外,更多的 RFA 后 TN 被归类为 ACR-TI-RADS 类别 4 和 5(40.1%对 70.1%,p<0.0001)。

结论

射频消融治疗对 TN 有效。消融前囊肿成分、消融后 3 个月的 TN 体积减少和边缘变化与 6 个月和 1 年的反应相关。临床医生应注意,RFA 后 TN 在 US 上的外观会显得奇特,错误地提示潜在恶性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验